Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Lockhart

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JAMA|December 2, 1988
Serving the underservedD C Lockhart
The Journal of Urology|July 12, 2005
Health issues of men: prevalence and correlates of erectile dysfunctionR Shabsigh, M A Perelman, D C Lockhart, et al.
International Journal of Cancer|July 27, 1999
Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T-cell activationA K Chan, D C Lockhart, W von Bernstorff, et al.
Surgery|January 16, 1999
Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligandW von Bernstorff, R A Spanjaard, A K Chan, et al.
Surgery|June 8, 2001
Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinomaD C Lockhart, A K Chan, S Mak, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JAMA|December 2, 1988
Serving the underservedD C Lockhart
The Journal of Urology|July 12, 2005
Health issues of men: prevalence and correlates of erectile dysfunctionR Shabsigh, M A Perelman, D C Lockhart, et al.
International Journal of Cancer|July 27, 1999
Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T-cell activationA K Chan, D C Lockhart, W von Bernstorff, et al.
Surgery|January 16, 1999
Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligandW von Bernstorff, R A Spanjaard, A K Chan, et al.
Surgery|June 8, 2001
Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinomaD C Lockhart, A K Chan, S Mak, et al.
Pageof 1